153 related articles for article (PubMed ID: 35836303)
1. The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy.
Heaphy CM; Joshu CE; Barber JR; Davis C; Lu J; Zarinshenas R; Giovannucci E; Mucci LA; Stampfer MJ; Han M; De Marzo AM; Lotan TL; Platz EA; Meeker AK
J Pathol Clin Res; 2022 Sep; 8(5):481-491. PubMed ID: 35836303
[TBL] [Abstract][Full Text] [Related]
2. Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes.
Heaphy CM; Joshu CE; Barber JR; Davis C; Zarinshenas R; De Marzo AM; Lotan TL; Sfanos KS; Meeker AK; Platz EA
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):676-680. PubMed ID: 31915143
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.
Heaphy CM; Yoon GS; Peskoe SB; Joshu CE; Lee TK; Giovannucci E; Mucci LA; Kenfield SA; Stampfer MJ; Hicks JL; De Marzo AM; Platz EA; Meeker AK
Cancer Discov; 2013 Oct; 3(10):1130-41. PubMed ID: 23779129
[TBL] [Abstract][Full Text] [Related]
4. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy.
Hamid AA; Gray KP; Huang Y; Bowden M; Pomerantz M; Loda M; Sweeney CJ
Eur Urol Oncol; 2019 Sep; 2(5):475-482. PubMed ID: 31411988
[TBL] [Abstract][Full Text] [Related]
5. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
[TBL] [Abstract][Full Text] [Related]
6. Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer.
Joshu CE; Heaphy CM; Barber JR; Lu J; Zarinshenas R; Davis C; Han M; Lotan TL; Sfanos KS; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2021 Apr; 14(4):463-470. PubMed ID: 33355185
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.
Joshu CE; Peskoe SB; Heaphy CM; Kenfield SA; Van Blarigan EL; Mucci LA; Giovannucci EL; Stampfer MJ; Yoon G; Lee TK; Hicks JL; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2015 Aug; 8(8):737-42. PubMed ID: 25990087
[TBL] [Abstract][Full Text] [Related]
8. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
Leapman MS; Nguyen HG; Cowan JE; Xue L; Stohr B; Simko J; Cooperberg MR; Carroll PR
Eur Urol; 2018 Nov; 74(5):668-675. PubMed ID: 30181067
[TBL] [Abstract][Full Text] [Related]
9. Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up.
Bill-Axelson A; Holmberg L; Garmo H; Taari K; Busch C; Nordling S; Häggman M; Andersson SO; Andrén O; Steineck G; Adami HO; Johansson JE
N Engl J Med; 2018 Dec; 379(24):2319-2329. PubMed ID: 30575473
[TBL] [Abstract][Full Text] [Related]
10. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.
Heaphy CM; Gaonkar G; Peskoe SB; Joshu CE; De Marzo AM; Lucia MS; Goodman PJ; Lippman SM; Thompson IM; Platz EA; Meeker AK
Prostate; 2015 Aug; 75(11):1160-6. PubMed ID: 25893825
[TBL] [Abstract][Full Text] [Related]
11. Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group.
Patel HD; Tosoian JJ; Carter HB; Epstein JI
JAMA Oncol; 2018 Jan; 4(1):89-92. PubMed ID: 28715578
[TBL] [Abstract][Full Text] [Related]
12. Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells.
Joshu CE; Peskoe SB; Heaphy CM; Kenfield SA; Mucci LA; Giovannucci EL; Stampfer MJ; Yoon G; Lee TK; Hicks JL; De Marzo AM; Meeker AK; Platz EA
Prostate; 2018 Feb; 78(3):233-238. PubMed ID: 29164645
[TBL] [Abstract][Full Text] [Related]
13. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
[TBL] [Abstract][Full Text] [Related]
15. Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes.
Alves de Inda M; van Strijp D; den Biezen-Timmermans E; van Brussel A; Wrobel J; van Zon H; Vos P; Baillie GS; Tennstedt P; Schlomm T; Houslay MD; Bangma C; Hoffmann R
Eur Urol Focus; 2018 Apr; 4(3):376-384. PubMed ID: 28753810
[TBL] [Abstract][Full Text] [Related]
16. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
[TBL] [Abstract][Full Text] [Related]
17. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
18. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
19. Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes.
Cooperberg MR; Cowan JE; Lindquist KJ; Kobayashi Y; Simko JP; Bengtsson H; Singh K; Ngo V; Avila A; Newcomb LF; Tretriakova M; Lin DW; Stone S; Carroll PR; Paris PL
Eur Urol; 2021 Jan; 79(1):141-149. PubMed ID: 33148472
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
